Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas J Hwang

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
The Lancet. Oncology|February 3, 2022
New EU regulation on health technology assessment of cancer medicinesThomas J Hwang, Kerstin N Vokinger
JAMA Pediatrics|August 12, 2014
New regulatory paradigms for innovative drugs to treat pediatric diseasesThomas J Hwang, Florence T Bourgeois
American Journal of Law & Medicine|November 1, 2017
Leveraging Novel and Existing Pathways to Approve New Therapeutics to Treat Serious Drug-Resistant InfectionsThomas J Hwang, Aaron S Kesselheim
BMJ (Clinical Research Ed.)|November 2, 2016
Public referendum on drug prices in the US: will it bring relief?Thomas J Hwang, Aaron S Kesselheim
JAMA Ophthalmology|February 13, 2015
Retinal implants and Medicare reimbursement policies for breakthrough treatments in ophthalmologyThomas J Hwang, Joseph B Ciolino
JAMA Oncology|July 9, 2016
Measuring the Value of New Medications and Implications for Medicare's Proposed Part B Drug Payment ModelThomas J Hwang, John L LaMattina
JAMA Pediatrics|November 14, 2017
Improving the Study of New Medicines for Children With Rare DiseasesFlorence T Bourgeois, Thomas J Hwang
Health Affairs (Project Hope)|February 10, 2016
Vaccine Pipeline Has Grown During The Past Two Decades With More Early-Stage Trials From Small And Medium-Size CompaniesThomas J Hwang, Aaron S Kesselheim
Annals of Internal Medicine|January 20, 2016
Breakthrough Medical Devices and the 21st Century Cures ActAaron S Kesselheim, Thomas J Hwang
The Lancet. Oncology|March 5, 2026
Clinical benefit and the Trump administration's cancer medicine reformsThomas J Hwang, Kerstin Noelle Vokinger
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
The Lancet. Oncology|February 3, 2022
New EU regulation on health technology assessment of cancer medicinesThomas J Hwang, Kerstin N Vokinger
JAMA Pediatrics|August 12, 2014
New regulatory paradigms for innovative drugs to treat pediatric diseasesThomas J Hwang, Florence T Bourgeois
American Journal of Law & Medicine|November 1, 2017
Leveraging Novel and Existing Pathways to Approve New Therapeutics to Treat Serious Drug-Resistant InfectionsThomas J Hwang, Aaron S Kesselheim
BMJ (Clinical Research Ed.)|November 2, 2016
Public referendum on drug prices in the US: will it bring relief?Thomas J Hwang, Aaron S Kesselheim
JAMA Ophthalmology|February 13, 2015
Retinal implants and Medicare reimbursement policies for breakthrough treatments in ophthalmologyThomas J Hwang, Joseph B Ciolino
JAMA Oncology|July 9, 2016
Measuring the Value of New Medications and Implications for Medicare's Proposed Part B Drug Payment ModelThomas J Hwang, John L LaMattina
JAMA Pediatrics|November 14, 2017
Improving the Study of New Medicines for Children With Rare DiseasesFlorence T Bourgeois, Thomas J Hwang
Health Affairs (Project Hope)|February 10, 2016
Vaccine Pipeline Has Grown During The Past Two Decades With More Early-Stage Trials From Small And Medium-Size CompaniesThomas J Hwang, Aaron S Kesselheim
Annals of Internal Medicine|January 20, 2016
Breakthrough Medical Devices and the 21st Century Cures ActAaron S Kesselheim, Thomas J Hwang
The Lancet. Oncology|March 5, 2026
Clinical benefit and the Trump administration's cancer medicine reformsThomas J Hwang, Kerstin Noelle Vokinger
Pageof 10